Ruthanna Hunter
Neurology · Jefferson City, MONPI 1821228404
Payments from drug & device makers
Across 178 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$440
- Novartis$396
- AbbVie$369
- Supernus Pharmaceuticals, Inc.$224
- Sanofi$189
- Eisai Inc.$176
- plus $1K from 33 others
What the payments were for
- Speaking & faculty fees$351%
- Travel & lodging$2248%
- Food & beverage$2,65189%
- Gifts$602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $440 |
| Novartis | 24 | $396 |
| AbbVie(2 entities) | 28 | $369 |
| Supernus Pharmaceuticals, Inc. | 31 | $224 |
| Sanofi | 13 | $189 |
| Eisai Inc. | 14 | $176 |
| Abbott | 4 | $142 |
| Teva Pharmaceuticals USA, Inc. | 6 | $88 |
| EMD Serono, Inc. | 3 | $68 |
| Amgen | 4 | $67 |
| Saol Therapeutics Inc. | 2 | $60 |
| Sunovion Pharmaceuticals Inc. | 3 | $52 |
| Medtronic(2 entities) | 3 | $51 |
| Lilly USA, LLC | 3 | $50 |
| Grifols USA, LLC | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Acorda Therapeutics, Inc | 2 | $35 |
| Biogen | 2 | $34 |
| Neurocrine Biosciences, Inc. | 2 | $34 |
| Acadia Pharmaceuticals Inc | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 2 | $32 |
| Lundbeck LLC | 2 | $32 |
| Ipsen Biopharmaceuticals, Inc | 2 | $31 |
| Kyowa Kirin, Inc. | 2 | $27 |
| Greenwich Biosciences, Inc. | 1 | $25 |
| Adamas Pharmaceuticals, Inc. | 2 | $25 |
| Zyla Life Sciences, Inc. | 2 | $23 |
| UCB, Inc. | 1 | $21 |
| Livanova USA, Inc. | 1 | $18 |
| SK Life Science, Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| AstraZeneca | 1 | $15 |
| CSL Behring | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Aprecia Pharmaceuticals, LLC | 1 | $14 |
| Bristol Myers Squibb | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL DBS$424
- MAYZENT$125
How this compares
$2,970 in reported general payments places this provider in the 55th percentile of 381 neurology providers in Missouri.
Other neurology in Jefferson City
- Randall BatemanSaint Louis$92.3M
- David HoltzmanSaint Louis$25.2M
- Robert NaismithSaint Louis$13.8M
- Eric McDadeSaint Louis$9.6M
- Robert BucelliSaint Louis$8.5M
- Barbara SniderSaint Louis$7M
- Curtis SchreiberBolivar$6.4M
- Gregory WuSaint Louis$5.7M
- Siddharth KaulBridgeton$5.7M
- Kenneth SharlinOzark$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.